Patients with systemic lupus erythematosus (SLE) treated with high-dose steroids appear to develop osteonecrosis (bone death) within one month of starting the therapy, according to a new report.
Patients with systemic lupus erythematosus (SLE) treated with high-dose steroids appear to develop osteonecrosis (bone death) within one month of starting the therapy, according to a new report.